Industry Views of sport-recreation - Made-in-China.com

Helsinn Gives Rights to Their Ghrelin Receptor Agonist to Chugai Pharma Marketing

Nov 14, 2013

Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...

Tags: Helsinn group, Pharma Marketing

Qatar Petroleum and Dubai Carbon Center of Excellence Signed a Memorandum of Understanding

Nov 14, 2013

Qatar Petroleum (QP) and the Dubai Carbon Center of Excellence (DCCE) have signed a memorandum of understanding (MOU) that establishes a clear framework of communication and effective coordination between the two parties to strengthen their ...

Tags: Qatar Petroleum, Dubai Carbon Center, MOU, strategic, partnership

US FDA Has Cleared The Company's Investigational New Drug (Ind) Application for Aerosurf

Nov 14, 2013

Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, has announced that the US Food and Drug Administration (FDA) has cleared the company's investigational new drug ...

Tags: Discovery Labs, Medicine

A.P. Pharma Has Initiated a Program to Expand Its Pipeline of Sustained Release Products

Nov 14, 2013

A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...

Tags: A.P.Pharma, Pipeline Expansion

US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent

Nov 14, 2013

US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...

Tags: Sagent Pharmaceuticals, Hydrochloride Injection

LPI Has Launched Its Generic Rabeprazole Sodium Delayed-release Tablets,20mg

Nov 14, 2013

Lupin Pharmaceuticals (LPI), a US subsidiary of India-based Lupin, has launched its generic Rabeprazole Sodium delayed-release tablets, 20mg. Earlier, the company had received final approval from the US Food and Drug Administration (FDA) ...

Tags: Lupin Pharma, tablets

The Vessel Atlantic Guardian Is Mobilising to The Gulf of Mexico

Nov 14, 2013

The vessel Atlantic Guardian, which has been working on a multi-client campaign in the Barents Sea since mid-April is mobilising to the Gulf of Mexico. The vessel will join the BOA Galatea under the current contract for PEMEX. Atlantic ...

Tags: vessel, Atlantic Guardian, BOA, PEMEX

BCI Chemical Corporation Was Presented with Frost & Sullivan Technology Innovation Award

Nov 14, 2013

BCI Chemical Corporation was presented with the Frost & Sullivan Technology Innovation Award for their achievements in the area of innovative value proposition in the Asia Pacific region at the 2013 Frost & Sullivan Asia Pacific Best ...

Tags: BCI, award, Frost&Sullivan, oil, gas

Luminant Will End Work on Their License for Two New Nuclear Reactors at Comanche Peak

Nov 14, 2013

Luminant will end work on their license for two new nuclear reactors at Comanche Peak according to a Reuters report, 11/08/13. Luminant's actions show once again that the so-called nuclear renaissance is fizzling out. New nuclear ...

Tags: Luminant, nuclear reactor, license, SEED

Emerson Process Management Opened Its New $25 Million Global Headquarters for The Design

Nov 14, 2013

Emerson Process Management, a business of Emerson, has opened its new $25 million global headquarters for the design, testing and manufacture of regulator technologies, including pressure regulator and relief valve solutions to help oil and ...

Tags: Emerson, technology, global, headquarter

ITGI Medical Has Signed a Strategic Cooperation Agreement with Vascular Solutions

Nov 14, 2013

Israeli bio-medical engineering company ITGI Medical has signed a strategic cooperation agreement with Vascular Solutions, a medical device company, to commercialize ITGI's Aneugraft Dx coronary covered stent in the US market. Pursuant to ...

Tags: ITGI Medical, Aneugraft DX Stent

Miracor Medical Systems Announced 30 Patients Have Been Treated with PICSO System

Nov 14, 2013

Austria-based Miracor Medical Systems has announced that 30 patients have been successfully treated with no device-related adverse events using its PICSO (pressure-controlled intermittent coronary sinus occlusion) system designed to improve ...

Tags: PICSO System, Medical Systems

Unilife Has Announced an Agreement with Medimmunefor Use in Medimmune's Pipeline

Nov 14, 2013

Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...

Tags: Unilife, Injectable Drug Delivery Services

Availability of Enseal G2 Articulating Tissue Sealer Will Be Announced by Ethicon

Nov 14, 2013

Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, has announced the availability of its ENSEAL G2 articulating tissue sealer in the US. Ethicon Endo-Surgery claims ENSEAL G2 is the first and only articulating advanced energy device ...

Tags: Ethicon Endo-Surgery

Titan Spine Reached a Milestone of 18,000 Implanted Endoskeleton Interbody Fusion Devices

Nov 14, 2013

Titan Spine, a medical device surface technology company, has reached a milestone of 18,000 implanted Endoskeleton interbody fusion devices since its inception. Titan Spine has announced that the annualized sales revenue run-rate for the ...

Tags: Titan Spine, medical device

Industry Views

Hot Products